ISRG - Intuitive Surgical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
560.65
+4.18 (+0.75%)
As of 10:20AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close556.47
Open559.64
Bid560.88 x 1800
Ask561.67 x 800
Day's Range556.83 - 561.97
52 Week Range337.80 - 572.96
Volume76,847
Avg. Volume638,468
Market Cap63.773B
Beta1.11
PE Ratio (TTM)82.68
EPS (TTM)6.78
Earnings DateOct 17, 2018 - Oct 22, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est569.80
Trade prices are not sourced from all markets
  • InTouch Health to Build an Internet of Medical Things Network for Intuitive
    PR Newswire1 hour ago

    InTouch Health to Build an Internet of Medical Things Network for Intuitive

    SANTA BARBARA, Calif., Sept. 20, 2018 /PRNewswire/ -- InTouch Health, the leading enterprise telehealth platform, today announced it has signed a multi-year licensing service agreement with Intuitive Surgical, Inc. (ISRG), the pioneer and a global technology leader in robotic-assisted, minimally invasive surgery. Under the agreement, the two companies will collaborate to deepen Intuitive's Internet of Medical Things (IoMT) network to connect into thousands of da Vinci surgical systems in medical institutions around the world on a single global network. InTouch Health's proprietary IoMT network will enable healthcare companies like Intuitive, to connect directly to their surgical systems worldwide to exchange real-time data for enhanced clinical insights, proactive service and maintenance monitoring, surgical collaboration between disparate locations, and the ability to extract data for data analytics and machine learning.

  • What Quest Diagnostics’ Valuation Trend Indicates
    Market Realist3 hours ago

    What Quest Diagnostics’ Valuation Trend Indicates

    In September 2018, of the total 18 analysts covering Quest Diagnostics (DGX), ten analysts have given Quest stock a “buy” or higher rating, and eight analysts have given Quest a “hold” rating. The mean rating for Quest stock is 2.22 with a target price of $116.86 implying an upside potential of 9% over Quest’s closing price of $107.22 on September 18, 2018.

  • How Quest Diagnostics Is Positioned in 2018
    Market Realist19 hours ago

    How Quest Diagnostics Is Positioned in 2018

    Quest Diagnostics (DGX) is a leading provider of diagnostic information services. Quest makes use of its database of clinical lab results to gain diagnostic insights that help to improve healthcare management. Quest’s diagnostics information services business (or DIS) provides data and insights based on routine, non-routine, and advanced clinical testing, as well as anatomic pathology testing and other diagnostic information services.

  • What’s the Upside Potential of Thermo Fisher Scientific Stock?
    Market Realist21 hours ago

    What’s the Upside Potential of Thermo Fisher Scientific Stock?

    So far in 2018, Thermo Fisher Scientific (TMO) stock has generated double-digit returns for investors. Boosted by its strong financial performance, it’s risen from $192.98 on January 2 to its current level of $240 in September.

  • What Thermo Fisher Scientific’s Gross Margin Trend Indicates
    Market Realist21 hours ago

    What Thermo Fisher Scientific’s Gross Margin Trend Indicates

    Thermo Fisher Scientific (TMO) is a leading provider of analytical instruments, equipment, reagents, and consumables. Thermo Fisher Scientific generated total revenue of $6.08 billion in the second quarter compared to $4.99 billion in the comparable period of 2017. Thermo Fisher generates revenue from product sales and services.

  • 7 ways to invest in the automation megatrend
    MarketWatch22 hours ago

    7 ways to invest in the automation megatrend

    To hear some politicians tell it, unfair trade and labor practices have been killing American factory jobs and punishing the U.S. economy for years — and 2018 is finally the year we fight back. As Michael Hicks and Srikant Devaraj of Ball State noted in a research report entitled “The Myth and Reality of Manufacturing in America,” productivity in the sector has exploded in the last decade or two thanks to technological innovations, with automation chief among them. For example, if productivity had remained constant from the year 2000 to 2010, U.S. manufacturers would have employed 20.9 million workers in 2010 to achieve that year’s total output, rather than just 12.1 million.

  • Here's Why You Should Hold AngioDynamics' (ANGO) Stock Now
    Zacksyesterday

    Here's Why You Should Hold AngioDynamics' (ANGO) Stock Now

    AngioDynamics (ANGO) to benefit from a solid product portfolio. However, the company???s core Peripheral Vascular business has been sluggish.

  • Veeva's Vault CDMS to Unify Clinical Data in Single Platform
    Zacksyesterday

    Veeva's Vault CDMS to Unify Clinical Data in Single Platform

    Veeva's (VEEV) cloud-based applications' market prospects bright.

  • ResMed Unveils AirFit F30, Expands AirFit Mask Portfolio
    Zacks2 days ago

    ResMed Unveils AirFit F30, Expands AirFit Mask Portfolio

    ResMed's (RMD) recent product launches will strengthen its position in the high-potential sleep-disordered breathing market.

  • Zacks2 days ago

    QIAGEN (QGEN) Partners DiaSorin to Extend QuantFERON Offers

    Per QIAGEN (QGEN), the latest LIAISON QuantiFERON-TB Plus Test is likely to tackle the growing transformation of global latent TB testing market into the modern blood-based QuantiFERON technology.

  • Cooper's MiSight Lens Effective in Checking Juvenile Myopia
    Zacks2 days ago

    Cooper's MiSight Lens Effective in Checking Juvenile Myopia

    Cooper's (COO) core CVI business gets a boost from MiSight's positive study results.

  • Can Intuitive Surgical (ISRG) Keep the Earnings Surprise Streak Alive?
    Zacks2 days ago

    Can Intuitive Surgical (ISRG) Keep the Earnings Surprise Streak Alive?

    Intuitive Surgical (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

  • Here's Why You Should Add Abbott (ABT) to Your Portfolio Now
    Zacks2 days ago

    Here's Why You Should Add Abbott (ABT) to Your Portfolio Now

    Abbott (ABT) continues to deliver strong and consistent performance in all segments. The company has also been hogging the limelight within Diabetic Care on progress with its FreeStyle Libre.

  • CVS Health (CVS) PBM Strengthens, Aetna Deal Shows Promise
    Zacks3 days ago

    CVS Health (CVS) PBM Strengthens, Aetna Deal Shows Promise

    A robust 2019 PBM selling season is a tailwind for CVS Health (CVS). Additionally, the company's milestone acquisition of Aetna might alter the whole healthcare landscape in the United States.

  • QIAGEN Collaborates With NeuMoDx, Expands NGS Portfolio
    Zacks3 days ago

    QIAGEN Collaborates With NeuMoDx, Expands NGS Portfolio

    QIAGEN (QGEN) forges ahead with deals to strengthen the NGS Platform.

  • DaVita Kidney Care Opens 150000-Square-Foot Campus in DeLand
    Zacks3 days ago

    DaVita Kidney Care Opens 150000-Square-Foot Campus in DeLand

    DaVita's (DVA) dialysis care in the United States gets a boost; market prospects solid.

  • Pacific Biosciences (PACB) Up as VGP Picks Flagship Sequel
    Zacks6 days ago

    Pacific Biosciences (PACB) Up as VGP Picks Flagship Sequel

    Pacific Biosciences (PACB) sees a slew of developments in its coveted SMRT Sequel platform.

  • Veeva Gains as MD&D Companies Pick Its Cloud-Based Services
    Zacks6 days ago

    Veeva Gains as MD&D Companies Pick Its Cloud-Based Services

    Veeva's (VEEV) focus on cloud-based services is likely to open up substantial opportunities for the company.

  • Pacific Biosciences (PACB) Jumps: Stock Rises 5.4%
    Zacks6 days ago

    Pacific Biosciences (PACB) Jumps: Stock Rises 5.4%

    Pacific Biosciences (PACB) was a big mover last session, as the company saw its shares rise more than 5% on the day amid huge volumes.

  • Here's Why You Should Invest in Penumbra (PEN) Stock Now
    Zacks7 days ago

    Here's Why You Should Invest in Penumbra (PEN) Stock Now

    The market is quite upbeat about Penumbra's (PEN) recently-closed buyout of a controlling stake in MVI Health, aimed at capturing the great potential of virtual reality application.

  • 3 Stocks to Watch as Bots Take Bigger Strides in US Healthcare
    Zacks7 days ago

    3 Stocks to Watch as Bots Take Bigger Strides in US Healthcare

    Robotics and mechatronics shape up the U.S. medical industry; three stocks that catch the eye.

  • Medtronic (MDT) Initiates ONYX ONE- Clear Study on DAPT
    Zacks8 days ago

    Medtronic (MDT) Initiates ONYX ONE- Clear Study on DAPT

    Following a DAPT interruption at one month on patients with a next generation DES, the Onyx ONE Clear Study by Medtronic (MDT) investigates risk of cardiac death, heart attack and stent thrombosis.

  • Stryker (SYK) to Acquire Invuity, Boost Surgical Portfolio
    Zacks8 days ago

    Stryker (SYK) to Acquire Invuity, Boost Surgical Portfolio

    Stryker (SYK) on an acquisition spree; latest buyout likely to aid its array of surgical instruments.

  • Genomic Health (GHDX) Hits a 52-Week High: What's Driving It?
    Zacks8 days ago

    Genomic Health (GHDX) Hits a 52-Week High: What's Driving It?

    Genomic Health (GHDX) sees increasing private coverage for the Oncotype DX GPS test within the prostate cancer space.

  • Motley Fool9 days ago

    How Intuitive Surgical, Inc. Shares Went Up 10% Last Month

    The robotic surgery specialist posted another big month on nothing more substantial than a single, tight-lipped analyst action.